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Abstract  The internet is now recognised as a growing international phenomenon. All kinds of 
products and services are being marketed over the internet to consumers throughout the world 
because country borders no longer restrict conducting business in the international marketplace. 
Though there are several advantages of online commerce, this form of marketing does raise 
ethical dilemmas, particularly when it comes to marketing healthcare products and information 
to consumers internationally. This paper examines some of these potential ethical concerns and 
provides some strategies for consumers and online pharmaceutical marketers to handle these 
dilemmas more appropriately.  
 
INTRODUCTION 
 
New models of doing business blossomed in the 1990s with the rapid growth of the internet1 and 
online trade has changed the way many businesses operate.2 Many businesses now feel 
compelled to have some form of internet presence (eg ordering, order tracking, e-mail, a business 
website), whether or not they actively use these tools to conduct business.3  This ‘internet mania’ 
is not surprising when one considers that 39 per cent of consumers logged onto the internet daily 
in 2002, up 10 per cent over the previous year.4 Industries once widely considered as being 
immune from the explosion in e-commerce are now quite rapidly incorporating the internet in 
their business operations, including healthcare businesses. For example, rapid technological 
advancements in the field of telecommunications are now also actively playing a significant role 
in defining pharmaceutical and alternative health businesses. The changes we have already seen 
and will continue to see, are not only in online pharmacy sales volume of traditional western 
medicine, but also in the number of different types of alternative medicinal approaches and 
products that are now being made available directly to consumers via the internet. Alternative 
medicines, such as herbal products and homeopathic products, are not just a passing trend in the 
US economy anymore. They are quite extensively and aggressively being marketed via the 
internet.5  
E-health refers to the convergence of various technologies such as the internet, computer 
telephony/interactive voice response, wireless communications, plus direct access to healthcare 
providers, healthcare management, healthcare education (perhaps via telemedicine) and wellness 
information.6 Although many technologies are and will continue to be involved in the 
development of e-health, the internet clearly has and will for the foreseeable future be the 
primary driver for the growth in this field of healthcare, according to both clinicians7 and 
consultants.8 Healthcare providers and consumers are more and more turning toward the 
internet,9 which appears to have significantly enhanced the ‘reach’, ie the number of 
unduplicated audience members who receive the promoted message, of many businesses, 
including healthcare. Between 2000 and 2001, the number of Americans regularly searching 
online for health information rose from 70 million10 to almost 100 million.11 Internet-based 
healthcare will be worth US$370 billion by 2004.12  
The internet has a tremendous potential of being of benefit to the healthcare consumer 
and provider in the following ways:  
• By providing vast amounts of information regarding healthcare products and services in a 
very convenient and rapid manner.13  
• By making available the latest healthcare research in a more timely manner as compared 
with its appearing in non-electronic print.14  
• By providing additional value-added services including cost savings for direct online 
purchases by consumers.15  
• By providing therapy (or e-therapy) to consumers via the internet at the consumer’s 
convenience.16  
• By providing both real-time and delayed consultation opportunities to practitioners and 
patients in remote locations where healthcare practitioners, especially specialists, may be 
few.17  
 
While approximately 55 per cent of Americans view the internet as a reliable source of 
healthcare information, compared with just under 30 per cent for newspapers and 28 per cent for 
television,18 it has been estimated that over 50 per cent of the healthcare-related information on 
the internet is not attributable to any authority and 7 per cent of the healthcare-related 
information provided on the internet is false.19 Despite the lack of veriability of health-related 
information on the internet, however, a Pew internet and American Life Project survey estimated 
that 55 per cent of Americans with internet access have used the internet to gain health 
information.20 The information technology revolution, as evidenced by the increasingly 
widespread use of the internet, promises to cause a shift in the US healthcare system away from 
the traditional delivery model.21 Unfortunately, despite the potential advantages of this shift for 
both the healthcare consumer and provider and the apparent widespread use by Americans of this 
approach for the gathering of healthcare information, the use of the internet may involve 
significant ethical concerns. Some of these are discussed in the next section.  
 
POTENTIAL ETHICAL DILEMMAS  
Most basic to the continuing development of e-health is trust by all participants in the process. 
Unfortunately, the security, use and distribution of patient data over the internet are significant 
problems.22 Many patients fear that their privacy will not be respected and their health 
information may be used to hurt them.23,24 For example, a survey conducted by CyberDialogue 
showed that 75 per cent of individuals seeking health information on the internet were concerned 
that the sites where they registered would share personal information with a third party without 
their permission.25 A Harris Interactive study found that 58 per cent of respondents lacked 
confidence in healthcare-related websites ability to protect personal information.26 There have 
been numerous published accounts of confidential health information being shared with 
unauthorised parties due to e-mail snafus.27  
A growing sense of mistrust regarding healthcare websites actual content fuels the 
development of internet healthcare ethical codes and standards.28,29 There are at least three 
content-related concerns. First, all who rely on the internet for healthcare information must be 
able to trust the reliability of the informational content obtained. Unfortunately, a survey 
conducted by Harris Interactive showed that consumers have a relatively low level of trust in 
websites sponsored by health insurers, hospitals and health plans.30 The same survey however, 
indicated that most consumers would feel more confident in a healthcare website which 
contained some kind of seal of approval or other indication of accreditation. Secondly, huge 
amounts and variety of content increase the possibility of errors and/or misinterpretation. 
Reliable, high quality content which is neither deceptive not misleading is mandatory if the e-
health industry is to gain users trust.31 Finally, as more and more people access the internet 
seeking healthcare-related information, websites may be tempted to track these individual web 
preferences, perhaps without their knowledge. Two techniques, one old and the other new, 
should be mentioned here. ‘Cookies’ have been used for this purpose for years to track individual 
internet movements by recording and reporting various websites visited. A newer approach 
however, called ‘spyware’ has recently become available. Spyware inserts software into others 
computer software which allows ‘carefully targeted advertising’.32 Patients may well be 
concerned that such tracking methods used to craft advertisements to them could also be used to 
track and collect other personal health information. Also, patients may feel that any healthcare 
information they obtain from such websites is tainted by commercial motives,33 leading to a 
further erosion of patient trust.  
Complaints about biased website materials and lax confidentiality have prompted internet 
healthcare participants to work with the healthcare community to develop both standards and 
ethical codes to build public confidence in the system.34 Of course, self-regulatory codes of 
ethics are often a tactical defence against legislative action by governments,35 but if done 
properly (eg addressing all participant ethical concerns), can be quite effective and useful. Self-
regulation may even be the preferred answer since legal control may not be practical. If 
legislation does become enacted, organisations intent on continuing the prohibited practices can 
easily move the website to another country and continue ‘business as usual’.36 Thus, the 
healthcare ethics movement prefers a self-regulatory approach to protecting privacy and building 
trust rather than a regulatory one.37  
There are several ethical dilemmas pertaining to promoting pharmaceutical and other 
healthcare products over the internet of which the consumer as well as healthcare professionals 
should be aware. Transactions over a medium such as the internet, where transactions are no 
longer any semblance of face-to-face, but instead are completely anonymous, may well ‘reduce 
informal social controls that restrict fraud and may provide opportunities for product 
misrepresentation’.38 Consumers should be concerned because they now have the ability to 
access healthcare information independently of healthcare practitioners and with this 
independent ability comes the associated requirement that consumers must independently 
evaluate the healthcare information obtained.  
Similarly, healthcare professionals should be concerned because they are responsible for 
consumer health and wellness. Some of the more serious ethical concerns are discussed below.  
 
Placement of unproven research on the Web  
Healthcare research is constantly being conducted all over the world. Before the results of these 
research activities become a widely acceptable reality and a viable product or protocol for 
treating disease, research studies need to be published in reputable, peer-reviewed publications. 
These publications need then to be widely circulated, mostly to the professional community, so 
that the research results can be replicated by other physicians and scientists. Once the results 
have been independently replicated by other researchers, they may be evaluated and possibly 
accepted by the healthcare community and eventually utilised for the treatment of patients. The 
internet however, provides a new avenue for researchers to publish their research, an avenue 
which requires neither peer review nor replication. The consumer needs to be aware that the 
information provided on many of these healthcare internet sites may not be in their best interest, 
as the research placed on them may be providing only one researcher’s opinion/study in an 
attempt to promote oneself as a ‘trend setter’.39,40 The average consumer is not qualified to 
determine the difference between ‘legitimate’ scientific research and ‘questionable’ scientific 
research and the Food and Drug Administration is concerned that misleading or unbalanced 
promotional information may harm patients.41  
 
Information on alternate medical therapy  
Alternative forms of medication and treatment are available and practised worldwide, but 
alternative medicine is more prevalent and most readily accepted by consumers in countries 
other than the USA.42 In the USA, alternative medical products and treatments have gained 
greater acceptance and demand for them has increased substantially over the past decade.43–45 
This increased interest by consumers in alternative medicine may be attributed in large part to 
the internet. But, this increased consumer interest also creates a major ethical dilemma for health 
professionals. Most consumers do not know that alternative health products are often 
regulated/classified as ‘food’ products. Food products do not go through the rigourous clinical 
trials that traditional health products do. Hence, it is much easier for them to obtain marketing 
clearance. In fact, many alternative health products are not even approved as ‘food’ products but 
may be marketed directly to consumers as ‘natural’ products. Many such ‘natural’ products can 
have serious adverse interactions with various prescription drugs. Health professionals may 
advise against the use of various so-called ‘natural’ products when used in conjunction with 
traditional therapies as they become aware of possible negative drug interactions due to the 
simultaneous use of these different types of products. Many alternative products, however, which 
are not available in the USA, can be acquired by the consumer from a foreign country via online 
marketers. The dangerous part is that there may be no research available for the consumer or 
even the health professional to make a calculated judgment regarding the potential hazards of 
these product combinations.  
 
Quality and cost issues  
Given the availability of pharmaceutical products over the Web, serious concerns have been 
raised regarding the quality of such products. The pharmaceutical industry is one of the most 
lucrative industries in the world economy,46 and many companies want a piece of that lucrative 
pie. Simply producing drugs is much cheaper without doing the research and development, 
which are involved in the creation of these products. In 2001, the pharmaceutical industry as a 
whole spent US$30 billion on research and development,47,48 with the average cost per drug 
between US$400 and US$800 million.49,50 By definition, foreign pharmaceutical product 
manufacturers are not bound by the stringent policies of the US Food and Drug Administration 
and many countries also do not recognise the patent protection of US products. This opens a new 
marketing avenue for foreign-based companies. Some foreign companies take advantage of the 
lack of universal patent protection laws and manufacture their own version of popular brand-
name products. Since these companies have not spent a lot of money on conducting research and 
development, they are able to bring products to the consumer at a significantly lower total cost 
compared with brand-name products. These costs are cut even further when the pharmaceutical 
products are made available directly to consumers over the internet via online companies, 
because of the resulting lower advertising and distribution costs. The availability of these 
products at a potentially much cheaper price than would be charged by traditional domestic 
distribution channels has at times created a rift between consumers, health professionals and 
retailers. Some may believe that health professionals are acting unethically when they suggest 
that the consumer should purchase pharmaceutical products in the local retail market rather than 
buying them over the internet. It may well be the case however, that the health professional is 
actually more concerned about the consumer and more concerned about the quality of the 
product than the cost of the product.  
 
Similar drug names  
One of the major problems that the healthcare industry has started to encounter over recent years 
is the availability of pharmaceutical products that have names which are quite similar, but they 
are intended to treat different health conditions. The major unethical situation that the internet 
can pose is that unethical companies may market their products using names similar to popular 
brand-name products. Consumers are often not aware of the correct spelling of a brand-name 
product; they are only aware of how the drug name is pronounced or sounds. This potential 
problem makes customers vulnerable to the unethical marketing practices of questionable online 
pharmaceutical product marketers. Consumers may risk losing not only their money, but also 
their health and even their lives.  
 
Litigation problems  
If there is a serious adverse event that is a direct result of unethical marketing practices of online 
pharmaceutical companies, which are based in a foreign country, it will be extremely difficult for 
a consumer to file a lawsuit against the perpetrator. The internet is so new that many countries 
have very few laws that regulate this industry. Unethical online pharmaceutical marketers may 
take advantage of this shortcoming and unsuspecting consumers. In some instances, it may even 
be hard for brand-name pharmaceutical product manufacturers to win a lawsuit against unethical 
marketers and manufacturers and prevent them from supplying questionable products directly to 
consumers. The advent of internet technology has been so rapid that legal systems governing the 
trade of goods and services in the domestic and the international markets have not been able to 
keep abreast of potential problems. Therefore, online pharmacies should be aware of the fact that 
they will soon be seeing some changes in legal systems that may affect their business 
operations.51 Whether these changes will help or harm the success of online pharmacies can only 
be determined in the future.  
 
Language concerns  
The vast majority of websites worldwide are written in English. The English that is spoken and 
written in different parts of the world however, varies significantly. There may be several ethical 
online pharmaceutical marketers that provide information to consumers in English that is only 
locally understandable. This may be understood in a different way, by consumers in different 
parts of the world, who also will have access to the websites of ethical marketers. Suddenly, an 
unintentional, unethical dilemma may be generated to which consumers become exposed. Hence, 
it is advisable that marketers use the most basic and simple English, which can cause the least 
amount of cross-cultural confusion.  
 
Believability of the information  
One of the most dangerous situations being caused by the internet, particularly as it relates to 
healthcare, deals with information believability and acceptability by consumers. Consumers 
often tend to believe what they perceive is in their best interest. Sometimes the information 
provided by the health professional to the patient may not be what the patient desires to hear, but 
it is accurate. Under such circumstances, a consumer may seek alternate sources of information 
to obtain a more desirable answer. Unfortunately, there are several marketers who are planning 
and hoping for this consumer shortcoming. Marketers may place highly desirable information on 
the internet and then hope that consumers will purchase the products which are strategically 
posted on the website. There are several online alternative product marketers who are using such 
strategy. At times, one wonders whether there is any disease state that some of these online 
marketers cannot treat or will not exploit.  
 
Consumer education regarding scientific information  
Healthcare professionals insist that patients lack sufficient education and training in 
pharmacology and therapeutics to adequately understand much of the healthcare information 
made available to them, let alone its implications.52 For example, about one-third of consumers 
feel that the product information provided in direct-to-consumer (DTC) advertisements for 
prescription pharmaceutical products is too difficult to understand,53 and only one-third of 
consumers even claim to read all or most of the brief summary, or the detailed information 
provided in DTC ads.54 Thus, the argument can certainly be made that providing health 
information and/or products directly to consumers over the internet could be extremely 
detrimental to the consumer’s wellness and also to his/her faith and belief in the healthcare 
system. It could also ignite a hypochondriac .re in consumers, as they may start believing that 
they suffer from each and every side effect related to product use as mentioned in the website. 
While this type of problem could also occur when a patient is prescribed and is taking a 
prescription drug, it is much less likely to occur, for two reasons. First, with prescription drugs, 
package inserts and/or information sheets are provided to consumers at the pharmacy or doctor’s 
office, which might well not occur with an online purchase. Secondly, with a face-to-face 
transaction, a healthcare professional is always available to address any questions or concerns 
expressed by a patient. With the consumer purchasing healthcare products via the internet, there 
could be no possibility of a consultation between the consumer and a healthcare professional 
before the product purchase decision is made. Potentially, this lack of consultation opportunity 
with internet purchases could affect the consumer purchasing decision regarding legitimate 
products.  
 
Lack of accompanying documentation  
The online pharmacies based in international countries are not obligated to provide 
documentation, such as patient package inserts, to consumers. In an investigative study by 
Fischman and Melton, several pharmaceutical products were acquired from online pharmacies.55 
Many of these products were shipped from foreign countries, including the UK, Spain and 
Thailand. Some products, which were shipped from some foreign countries, came with no 
documentation and also in mislabelled envelopes. This raises concerns regarding the ethical 
standards of some online pharmacies.  
 
SUMMARY GUIDELINES FOR ETHICAL ONLINE HEALTHCARE MARKETERS  
The following is a list of some steps that ethical online marketers can take in order to reduce 
consumer concerns regarding the reliability of such organisations.  
• Provide real names and the physical address/location for online pharmacies and other 
healthcare companies. Aliases for names and post office addresses may tend to raise red 
flags regarding the legitimacy of an organisation.   
• Provide the ‘technical’ information in layman terms. Use appropriate word processing 
software to determine the desired readability needed to understand the information. One 
should keep in mind that the recommended reading level for healthcare consumers is 
fifth-to-seventh   
grade.56   
• Avoid using scientific jargon. Most individuals accessing the website would certainly be 
predominately lay people who would not be expected to understand formal healthcare 
terminology.   
• Avoid having automatic links to other websites popping up in the consumer’s computer 
when they are accessing your website. This irritating and intrusive approach57–59 can 
create a detrimental impression in the consumer’s mind that this website is more 
interested in its own revenues than providing quality health to consumers.   
• Provide references where the consumer can go to find more information about a website. 
The website should in fact encourage consumers to check with references to ensure that 
ethical standards are maintained by this website.   
• Prominently display the organisation’s compliance with an accepted Code of Ethics, such 
as Health Internet Ethics or Hi-Ethics,60,61 on the website home page. An ethics code can 
reassure consumers regarding the ethical nature of a website.  
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